Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rare Revolution Magazine is a leading digital publication and media platform dedicated to the global rare disease community. Founded in 2016 and published by Rare Revolution Publishing LTD (part of NRG Collective), the company provides a multi-stakeholder platform that amplifies the voices of patients, advocates, and healthcare professionals. Its offerings include a quarterly digital magazine, the RARE Revolution insider for industry professionals, and the RARE Youth Revolution program for young people affected by rare conditions. Rare Revolution partners with major pharmaceutical and biotech companies to facilitate patient engagement, raise awareness for clinical trials, and provide educational content across the rare disease landscape. The company also utilizes advanced technology, such as the Cognito AI Librarian, to help users navigate complex rare disease information.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rare Revolution.